Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Alphabet Inc Class A (GOOGL) vs Immunovant Inc. Common Stock (IMVT) Price & Performance

Alphabet Inc Class ATrade
Immunovant Inc. Common StockTrade

Price performance (Past 24H)

Key statistics

Alphabet Inc Class A vs Immunovant Inc. Common Stock — how do they compare? Alphabet Inc Class A trades at $350.7 (market cap $4.27T), while Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B). The key difference: Alphabet Inc Class A is far larger — about 645× Immunovant Inc. Common Stock's market cap, and Alphabet Inc Class A pays a 0.25% dividend while Immunovant Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Alphabet Inc Class A for 85 Days and Immunovant Inc. Common Stock for 0 Days on average.

GOOGLIMVT
Market Cap
$4.27T$6.62B
Volume
20,474,1401,131,364
Sector
MediaHealth
52-Week High
$402.62$44.96
52-Week Low
$236.59$17.03
Typical Hold Time
85 Days0 Days
Enterprise Value
$4.16T$5.72B
Dividend Yield
0.25%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Alphabet Inc Class A

Alphabet (GOOGL) trades at $350.50, up 0.81% today, with a bullish technical signal and strong earnings beats in recent quarters. The stock shows robust fundamentals, including a 32.8% net income margin in 2025 and projected revenue growth to $445.9B in 2026. Analyst consensus is overwhelmingly positive, with an 86.75% buy rating and a $431.83 price target. Recent news highlights AI-driven growth opportunities and strategic partnerships.

The outlook for GOOGL remains favorable due to strong financial performance, AI integration, and analyst optimism. Key risks include regulatory scrutiny and market volatility. With solid cash flow and expanding profitability, the stock presents a compelling opportunity for growth-oriented investors, though attention to competitive and macroeconomic factors is advised.

Immunovant Inc. Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GOOGL
34% Buy66% Sell
Avg holding period · 85 Days
IMVT
100% Buy0% Sell
Avg holding period · 0 Days

Top news

Latest headlines on both assets

About Alphabet Inc Class A

Alphabet, the parent company of Google, earns nearly 90% of its revenue from Google services, mainly through advertising. Other revenue comes from subscriptions (YouTube TV, YouTube Music), platform sales (Play Store purchases), and devices (Pixel, Chromebooks, Chromecast). Google Cloud contributes around 10%, while investments in self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.

Read more on GOOGL →

About Immunovant Inc. Common Stock

Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.

Read more on IMVT →